Pinikehl D4 Zäpfchen Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

pinikehl d4 zäpfchen

ebi-pharm ag - fomes pinicola d4 - zäpfchen - fomes pinicola d4 trituratio 200 mg, excipiens pro suppositorio. - gemäss homöopathischem arzneimittelbild bei fieberanfällen, begleitet von anhaltender Übelkeit mit oberbauchschmerzen - farmaci omeopatici

Jetrea Європейський Союз - італійська - EMA (European Medicines Agency)

jetrea

inceptua ab - ocriplasmina - malattie della retina - oftalmologici - jetrea è indicato negli adulti per il trattamento della trazione vitreomaculare (vmt), anche se associato a un foro maculare di diametro inferiore o uguale a 400 micron.

Pemazyre 4,5 mg compresse Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

pemazyre 4,5 mg compresse

incyte biosciences international sàrl - pemigatinibum - compresse - pemigatinibum 4.5 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 0.176 mg, magnesii stearas, pro compresso. - cholangiocarcinome - synthetika

Pemazyre 9 mg compresse Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

pemazyre 9 mg compresse

incyte biosciences international sàrl - pemigatinibum - compresse - pemigatinibum 9 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 0.352 mg, magnesii stearas, pro compresso. - cholangiocarcinome - synthetika

Pemazyre 13,5 mg compresse Швейцарія - італійська - Swissmedic (Swiss Agency for Therapeutic Products)

pemazyre 13,5 mg compresse

incyte biosciences international sàrl - pemigatinibum - compresse - pemigatinibum 13.5 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 0.528 mg, magnesii stearas, pro compresso. - cholangiocarcinome - synthetika

Lytgobi Європейський Союз - італійська - EMA (European Medicines Agency)

lytgobi

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - agenti antineoplastici - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

TAXOL Італія - італійська - AIFA (Agenzia Italiana del Farmaco)

taxol

cheplapharm arzneimittel gmbh - paclitaxel - paclitaxel